Reneo Pharmaceuticals, Inc. (RPHM) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 58 transactions totaling $35.6M, demonstrating a bullish sentiment with $32.0M in net insider flow. The most recent transaction on Sep 25, 2024 involved a purchase of 68,746 shares valued at $103.1K.
No significant insider buying has been recorded for RPHM in the recent period.
No significant insider selling has been recorded for RPHM in the recent period.
Based on recent SEC filings, insider sentiment for RPHM is bullish with an Insider Alignment Score of 95/100 and a net flow of $32.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Reneo Pharmaceuticals, Inc. (RPHM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading RPHM stock, having executed 58 transactions in the past 90 days. The most active insider is Holdings A/s Novo (Executive), who has made 3 transactions totaling $10.7M.
Get notified when executives and directors at RPHM file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 25, 2024 | Michael Leonard Braden | Executive | Purchase | 68,746 | $1.50 | $103.1K | |
| Sep 24, 2024 | Michael Leonard Braden | Executive | Purchase | 29,600 | $1.41 | $41.7K | |
| Sep 18, 2024 | Michael Leonard Braden | Executive | Purchase | 806 | $1.40 | $1.1K | |
| Sep 17, 2024 | Michael Leonard Braden | Executive | Purchase | 55,300 | $1.36 | $75.2K | |
| Sep 16, 2024 | Michael Leonard Braden | Executive | Purchase | 172,747 | $1.37 | $236.7K | |
| Sep 13, 2024 | Michael Leonard Braden | Executive | Purchase | 150,000 | $1.31 | $196.5K | |
| Sep 12, 2024 | Michael Leonard Braden | Executive | Purchase | 36,176 | $1.40 | $50.6K | |
| Aug 14, 2024 | Michael Leonard Braden | Executive | Purchase | 100,487 | $1.41 | $141.7K | |
| Aug 13, 2024 | Michael Leonard Braden | Executive | Purchase | 171,339 | $1.39 | $238.2K | |
| May 14, 2024 | Michael Leonard Braden | Executive | Purchase | 335,000 | $1.54 | $515.9K | Large |
| May 14, 2024 | Michael Leonard Braden | Executive | Purchase | 79,281 | $1.56 | $123.7K | |
| Aug 28, 2023 | Hall Ashley | Executive | Option Exercise | 15,625 | $1.80 | $28.1K | |
| Aug 28, 2023 | Hall Ashley | Executive | Sale | 15,625 | $6.28 | $98.1K | |
| Jul 26, 2023 | G. Grey Michael | Executive | Gift | 50,000 | $N/A | $0 | |
| Jun 23, 2023 | A/s Novo Holdings | Executive | Sale | 100,000 | $7.10 | $710.0K | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 36 | $33.8M | 94.1% |
Sale(S) | 3 | $1.8M | 4.9% |
Exercise(M) | 3 | $346.7K | 1.0% |
Gift(G) | 2 | $0 | 0.0% |
Award(A) | 5 | $0 | 0.0% |
Conversion(C) | 9 | $0 | 0.0% |
Insiders at Reneo Pharmaceuticals, Inc. are accumulating shares at an accelerated pace. With 13 insiders making 58 transactions totaling $33.8M in purchases versus $1.8M in sales, the net buying activity of $32.0M signals strong executive confidence. Holdings A/s Novo (Executive) leads the buying activity with $10.7M in transactions across all time.